Today I read about a $1.7 million grant awarded to a team of scientists at the James P. Wilmot Cancer Center at the University of Rochester Medical Center for the development of new therapies attacking leukemic stem cells. And one of the substances under examination is parthenolide, which seems to be the [...]
Today I read about a $1.7 million grant awarded to a team of scientists at the James P. Wilmot Cancer Center at the University of Rochester Medical Center for the development of new therapies attacking leukemic stem cells. And one of the substances under examination is parthenolide, which seems to be the [...]